Sentinus, LLC Merck & Co., Inc. Transaction History
Sentinus, LLC
- $415 Million
- Q3 2025
A detailed history of Sentinus, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sentinus, LLC holds 6,092 shares of MRK stock, worth $565,703. This represents 0.12% of its overall portfolio holdings.
Number of Shares
6,092
Previous 3,745
62.67%
Holding current value
$565,703
Previous $296,000
72.64%
% of portfolio
0.12%
Previous 0.08%
Shares
9 transactions
Others Institutions Holding MRK
# of Institutions
3,880Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...